← All stocks

Nuvation Bio Inc.

NUVB Net selling
CIK 0001811063 #1916 in the set updated 18 Sep 2026
Bought (120 mo)
$24.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$76.26M
$0.00 on a plan · $9.73M straight out of an exercise
Sold at will
$66.53M
11 of 29 sales
Net
−$51.80M
−$42.07M against sales at will

By person

24 insiders · 71 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Omega Fund V, L.P. entity
10% owner
$64.30M (8)
−$64.30M
48,669,713
$345.19M
+1.8%
NODELMAN OLEG
Director
$14.78M (13)
$2.07M (2)
+$12.71M
31,751,919
$225.20M
+151.4%
EcoR1 Panacea Holdings, LLC entity
Director
$3.90M (1)
+$3.90M
390,000
$2.77M
Hattersley Gary
CHIEF SCIENTIFIC OFFICER
$3.88M (4) scheduled
−$3.88M
0
$0.00
Cui Xiangmin
Director
$2.32M (4)
+$2.32M
17,062,202
$121.01M
Liu Dongfang
CHIEF MEDICAL OFFICER
$1.92M (8) scheduled
−$1.92M
18,000
$127.66K
0.0%
Hung David
PRESIDENT AND CEO
$1.71M (3)
+$1.71M
59,281,054
$420.44M
+1,332,059%
Hanley David C.
CHIEF TECHNICAL OPERATIONS
$1.43M (1) scheduled
−$1.43M
24,000
$170.22K
0.0%
Wentworth Kerry
CHIEF REGULATORY OFFICER
$89.74K (2)
$1.47M (3) scheduled
−$1.38M
53,000
$375.90K
+1,667%
Markel Stacy
CHIEF PEOPLE OFFICER
$17.10K (1)
$753.19K (1) scheduled
−$736.09K
32,591
$231.15K
+44.3%
Mashal Robert
Director
$505.24K (5)
+$505.24K
225,000
$1.60M
BLICKENSTAFF KIM D
Director
$500.09K (1)
+$500.09K
172,189
$1.22M
FALBERG KATHRYN E
Director
$483.84K (4)
+$483.84K
250,000
$1.77M
Sauvage Philippe
Chief Financial Officer
$13.22K (2)
$286.37K (1) scheduled
−$273.15K
54,131
$383.92K
+692.4%
Wang Junyuan Jerry
CEO, ANHEART THERAPEUTICS LTD.
$162.88K (1)
−$162.88K
6,112,686
$43.35M
Sjogren Colleen
Chief Commercial Officer
$90.35K (1)
+$90.35K
81,000
$574.48K
+161.3%
Bazemore Robert B
Director
$49.90K (1)
+$49.90K
5,000
$35.46K
WELCH DANIEL G
Director
659,947
$4.68M
VERNON W ANTHONY
Director
304,100
$2.16M
Makunje Moses
SEE REMARKS
68,137
$483.25K
+292.1%
Hasnain Faheem
Director
55,000
$390.08K
Sharp Shalini
Director
35,000
$248.23K
COOPER GRAHAM K
Director
25,000
$177.31K
BRADBURY DANIEL
Director
25,000
$177.31K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Hattersley Gary
19 Aug 2026
CHIEF SCIENTIFIC OFFICER
Sold after exercise
100,000
$7.09
$709.24K
Sauvage Philippe
23 Jun 2026
Chief Financial Officer
Sold after exercise
47,668
$6.01
$286.37K
Wentworth Kerry
23 Jun 2026
CHIEF REGULATORY OFFICER
Sold after exercise
63,000
$6.02
$379.19K
Markel Stacy
23 Jun 2026
CHIEF PEOPLE OFFICER
Sold after exercise
125,000
$6.03
$753.19K
Liu Dongfang
17 Apr 2026
CHIEF MEDICAL OFFICER
Sold after exercise
50,000
$5.02
$251.00K
Wentworth Kerry
17 Apr 2026
CHIEF REGULATORY OFFICER
Sold after exercise
36,750
$5.01
$184.28K
Wentworth Kerry
6 Apr 2026
CHIEF REGULATORY OFFICER
Sold after exercise
200,000
$4.52
$903.56K
Liu Dongfang
1 Dec 2025
CHIEF MEDICAL OFFICER
Sold after exercise
150,000
$7.82
$1.17M
Liu Dongfang
26 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$8.00
$80.00K
Liu Dongfang
25 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
10,000
$7.50
$75.00K
Liu Dongfang
20 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$7.00
$140.07K
Hattersley Gary
20 Nov 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
300,000
$7.23
$2.17M
Hattersley Gary
20 Nov 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
69,051
$7.23
$499.03K
Liu Dongfang
19 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$5.10
$76.55K
Hanley David C.
19 Nov 2025
CHIEF TECHNICAL OPERATIONS
Sold after exercise
200,000
$7.14
$1.43M
Liu Dongfang
17 Nov 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$4.77
$71.48K
Hattersley Gary
27 Oct 2025
CHIEF SCIENTIFIC OFFICER
Sold after exercise
100,000
$5.02
$502.46K
Liu Dongfang
2 May 2025
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$2.50
$50.02K

What was left out

Form 4 filings counted 146
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 18
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 114,572,402
Sales filed before the plan box existed 10
History held since 6 Jul 2020